The biotech sector is entering 2026 with a positive outlook, characterized by reasonable valuations, robust oncology momentum and supportive policy tailwinds. This combination is...
Co-Listing Expands U.S. Investor Access and Visibility in World’s Largest Aviation and Capital Markets
Syntholene Energy CORP (TSXV: ESAF,OTC:SYNTF) (OTCQB: SYNTF) (FSE: 3DD0) (‘Syntholene’ or...